🚀 #NDLR2026 is proud to announce its full scientific program! Join us for an unmissable gathering of global leaders sharing the latest breakthroughs in blood cancer research!
#BloodCancerResearch #MPN #Myeloma #ALL #AML #Lymphoma #MDS #PediatricLeukemia #SpatialProfiling #CML

We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.

We are excited to announce #NDLR2026 speaker, clinician-scientist Prof Rishi Kotecha from the Kids Research Institute. His research aims to develop novel #CancerTherapies for #ChildhoodCancer. He is also leading #ClinicalTrails to improve outcomes for children with #Leukemia.

We are excited to introduce #NDLR2026 speaker Dr Jennifer Devlin, one of from @petermaccc.bsky.social. Jennifer’s research focuses on dissecting the molecular mechanisms that control #GeneExpression to identify transcriptional vulnerabilities that may be exploited for #CancerTreatment.

We are honoured to welcome clinician-scientist Prof Steven Lane from @qimrb.bsky.social as a speaker to #NDLR2026. Steven’s research concentrates on understanding how #leukemia stem cells in #AcuteMyeloidLeukemia and #MyeloproliferativeNeoplasm can regenerate leukemia.

We are excited to announce our new #NDLR2026 Meet-the-Editor session, with Editors-in-Chief, Prof Andrew Roberts, @bloodjournals.hematology.org and Prof @jancools.bsky.social, @hemasphere-journal.bsky.social who will share their invaluable insights on #publishing in high-impact #hematology journals.

We are thrilled to announce that Associate Professor @juliamaxson.bsky.social from @ohsuknight.bsky.social, USA, will be joining us at #NDLR2026. Julia's research focuses on investigating the cellular and molecular changes that cause myeloid #Leukemia.

🚨 Call for Abstracts Now Open #NDLR2026 🚨

Only 3 weeks left to submit your abstracts!

🗓 Abstract submission closes 23 September 2025
🩸 Submit now: www.ndlr.org.au
🎟️ Earlybird Registration is now open – secure your spot today!

#BloodCancer #CancerResearch #ChildhoodCancer

🚨 Call for Abstracts Now Open – #NDLR2026 🚨

🗓 Abstract submission closes 23 September 2025
🧬 Submit now: www.ndlr.org.au

Plus, Earlybird Registration is now open – secure your spot today! #BloodCancer #CancerResearch #ChildhoodCancer

We are honoured to welcome Professor John D. Crispino, from
@stjude.bsky.social as speaker to #NDLR2026. John’s research focuses on mechanisms of #Leukemia development in children with Down syndrome and the malignant progression of #MyelodysplasticSyndrome and #MyeloproliferativeNeoplasms.

If your #NHMRC ideas grant was unsuccessful and you have a story to share about the impact of this on your #biomedicalresearch, career, team - get in touch. Federal DOH have asked #NARF to collect stories of impact of low funding. #SaveOzScience #DiscoveriesNeedDollars #EMCRs